EP
INSM icon

Eversept Partners’s Insmed INSM Stock Holding History

Eversept Partners’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.4M Buy
+94,000
New +$14.5M 0.81% 30

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Eversept Partners's INSM Position: Q4 2024 in Review

Eversept Partners sold out of Insmed (INSM) in Q4 2024, closing a stake of 1,089,404 shares — an estimated $79.5M sold.

Eversept Partners first reported a position in INSM in Q2 2024 and held it in 2 quarters. The position peaked at $79.5M in Q3 2024. 438 funds tracked by Wall St. Rank hold INSM as of Q4 2024.

  • Eversept Partners reported no remaining Insmed position as of Q4 2024 after selling out during the quarter.
  • Eversept Partners sold 1,089,404 Insmed shares in Q4 2024, an estimated $79.5M.
  • Eversept Partners first reported a position in Insmed in Q2 2024 and held it in 2 quarters.
  • Eversept Partners's Insmed position peaked at $79.5M in Q3 2024.
  • 438 funds tracked by Wall St. Rank held Insmed as of Q4 2024.

Based on Eversept Partners's 13F filing for Q4 2024, filed 14 Feb 2025.